161 related articles for article (PubMed ID: 35750133)
1. Vascular bursts-mediated tumor accumulation and deep penetration of spherical nucleic acids for synergistic radio-immunotherapy.
Liu J; Guo L; Mi Z; Liu Z; Rong P; Zhou W
J Control Release; 2022 Aug; 348():1050-1065. PubMed ID: 35750133
[TBL] [Abstract][Full Text] [Related]
2. Tumor-Associated Enzyme-Activatable Spherical Nucleic Acids.
Zhang W; Callmann CE; Meckes B; Mirkin CA
ACS Nano; 2022 Jul; 16(7):10931-10942. PubMed ID: 35849553
[TBL] [Abstract][Full Text] [Related]
3. Combining Nanomedicine and Immunotherapy.
Shi Y; Lammers T
Acc Chem Res; 2019 Jun; 52(6):1543-1554. PubMed ID: 31120725
[TBL] [Abstract][Full Text] [Related]
4. Tumor cell lysate-loaded immunostimulatory spherical nucleic acids as therapeutics for triple-negative breast cancer.
Callmann CE; Cole LE; Kusmierz CD; Huang Z; Horiuchi D; Mirkin CA
Proc Natl Acad Sci U S A; 2020 Jul; 117(30):17543-17550. PubMed ID: 32669433
[TBL] [Abstract][Full Text] [Related]
5. DTX@VTX NPs synergy PD-L1 immune checkpoint nanoinhibitor to reshape immunosuppressive tumor microenvironment for enhancing chemo-immunotherapy.
Zhang R; Wan Y; Lv H; Li F; Lee CS
J Mater Chem B; 2021 Sep; 9(36):7544-7556. PubMed ID: 34551052
[TBL] [Abstract][Full Text] [Related]
6. Hydrogel/nanoparticles-mediated cooperative combination of antiangiogenesis and immunotherapy.
Yang A; Sheng S; Bai Y; Xing G; Yu X; Zhu D; Mei L; Dong X; Lv F
Acta Biomater; 2022 Nov; 153():124-138. PubMed ID: 36179979
[TBL] [Abstract][Full Text] [Related]
7. Spherical nucleic acid nanoparticle conjugates as an RNAi-based therapy for glioblastoma.
Jensen SA; Day ES; Ko CH; Hurley LA; Luciano JP; Kouri FM; Merkel TJ; Luthi AJ; Patel PC; Cutler JI; Daniel WL; Scott AW; Rotz MW; Meade TJ; Giljohann DA; Mirkin CA; Stegh AH
Sci Transl Med; 2013 Oct; 5(209):209ra152. PubMed ID: 24174328
[TBL] [Abstract][Full Text] [Related]
8. Applications of Spherical Nucleic Acid Nanoparticles as Delivery Systems.
Mokhtarzadeh A; Vahidnezhad H; Youssefian L; Mosafer J; Baradaran B; Uitto J
Trends Mol Med; 2019 Dec; 25(12):1066-1079. PubMed ID: 31703931
[TBL] [Abstract][Full Text] [Related]
9. Intelligent Gold Nanoparticles with Oncogenic MicroRNA-Dependent Activities to Manipulate Tumorigenic Environments for Synergistic Tumor Therapy.
Wang X; Yang T; Yu Z; Liu T; Jin R; Weng L; Bai Y; Gooding JJ; Zhang Y; Chen X
Adv Mater; 2022 Apr; 34(15):e2110219. PubMed ID: 35170096
[TBL] [Abstract][Full Text] [Related]
10. Reeducating Tumor-Associated Macrophages Using CpG@Au Nanocomposites to Modulate Immunosuppressive Microenvironment for Improved Radio-Immunotherapy.
Cao Y; Ding S; Zeng L; Miao J; Wang K; Chen G; Li C; Zhou J; Bian XW; Tian G
ACS Appl Mater Interfaces; 2021 Nov; 13(45):53504-53518. PubMed ID: 34704726
[TBL] [Abstract][Full Text] [Related]
11. Engineered a dual-targeting biomimetic nanomedicine for pancreatic cancer chemoimmunotherapy.
Wang M; Hu Q; Huang J; Zhao X; Shao S; Zhang F; Yao Z; Ping Y; Liang T
J Nanobiotechnology; 2022 Feb; 20(1):85. PubMed ID: 35177078
[TBL] [Abstract][Full Text] [Related]
12. Targeting tumor associated macrophages: The new challenge for nanomedicine.
Andón FT; Digifico E; Maeda A; Erreni M; Mantovani A; Alonso MJ; Allavena P
Semin Immunol; 2017 Dec; 34():103-113. PubMed ID: 28941641
[TBL] [Abstract][Full Text] [Related]
13. Glycocalyx-Mimicking Nanoparticles Improve Anti-PD-L1 Cancer Immunotherapy through Reversion of Tumor-Associated Macrophages.
Zhang Y; Wu L; Li Z; Zhang W; Luo F; Chu Y; Chen G
Biomacromolecules; 2018 Jun; 19(6):2098-2108. PubMed ID: 29634251
[TBL] [Abstract][Full Text] [Related]
14. In Vivo Behavior of Ultrasmall Spherical Nucleic Acids.
Callmann CE; Vasher MK; Das A; Kusmierz CD; Mirkin CA
Small; 2023 Jun; 19(24):e2300097. PubMed ID: 36905236
[TBL] [Abstract][Full Text] [Related]
15. A spherical nucleic acid platform based on self-assembled DNA biopolymer for high-performance cancer therapy.
Zheng J; Zhu G; Li Y; Li C; You M; Chen T; Song E; Yang R; Tan W
ACS Nano; 2013 Aug; 7(8):6545-54. PubMed ID: 23841478
[TBL] [Abstract][Full Text] [Related]
16. Salicylic acid-based hypoxia-responsive chemodynamic nanomedicines boost antitumor immunotherapy by modulating immunosuppressive tumor microenvironment.
Sun K; Yu J; Hu J; Chen J; Song J; Chen Z; Cai Z; Lu Z; Zhang L; Wang Z
Acta Biomater; 2022 Aug; 148():230-243. PubMed ID: 35724919
[TBL] [Abstract][Full Text] [Related]
17. Development of Spherical Nucleic Acids for Prostate Cancer Immunotherapy.
Qin L; Wang S; Dominguez D; Long A; Chen S; Fan J; Ahn J; Skakuj K; Huang Z; Lee A; Mirkin C; Zhang B
Front Immunol; 2020; 11():1333. PubMed ID: 32733447
[TBL] [Abstract][Full Text] [Related]
18. Dual inhibition of CSF1R and MAPK pathways using supramolecular nanoparticles enhances macrophage immunotherapy.
Ramesh A; Brouillard A; Kumar S; Nandi D; Kulkarni A
Biomaterials; 2020 Jan; 227():119559. PubMed ID: 31670078
[TBL] [Abstract][Full Text] [Related]
19. Bioinspired immuno-radio-enhancers toward synergistic nanomedicine through radiation-induced abscopal effects and immunocheckpoint blockade therapies.
Zhang P; Chen H; Chen C; Liu X; Cheng H; Wu Y; Wang X; Liu G; Zeng Y
Biomater Sci; 2023 Nov; 11(22):7327-7338. PubMed ID: 37847063
[TBL] [Abstract][Full Text] [Related]
20. Spherical nucleic acids-based nanoplatforms for tumor precision medicine and immunotherapy.
Liu S; Yu CY; Wei H
Mater Today Bio; 2023 Oct; 22():100750. PubMed ID: 37545568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
